July 12, 2023
EDUCATIONAL PEARL
Head and Neck Melanoma: Malignant cancer of melanocytes
Presenting Symptoms:
- ABCDE 
 A: Asymmetry
 B: Irregular borders
 C: Color changes (red, blue, white spots in brown/black patches)
 D: Diameter > 6 mm
 E: Evolving
- “Ugly Duckling” sign: Nevus evidently different than other surrounding nevi 
- Most common head and neck sites: occipital scalp and skin of cheek 
- Risk factors: - UV-B exposure 
- Severe sunburns in childhood 
- Pale skin (blue-green eyes) 
- Immunosuppression 
- Familial dysplastic nevus syndrome 
- Previous melanoma 
 
- Histopathology: Melanocyte cells that are neural crest in origin (S-100 positive) - Types of melanomas include: - Superficial spreading: Most common; 70% from preexisting junctional nevi; horizontal phase transitions to vertical phase (ulceration); 
- Nodular: Most aggressive; may present on non sun-exposed skin; worst prognosis 
- Lentigo Maligna Melanoma: Arises from lentigo maligna (melanoma in-situ from proliferation of melanocytes in basalis layer) in sun-exposed skin; common in the elderly; common on head and neck; confined to epidermis 
- Acral Lentiginous: Found on soles of feet or hands, more common in darker skin tones 
- Mucosal melanoma: Found in mucosa instead of skin; poor prognosis; <10% of head and neck melanomas 
- Amelanotic: Poor prognosis 
- Desmoplastic 
 
- Depth Classification: Breslow Thickness - Depth of invasion in mm 
- < 1 mm = thin melanoma 
- > 1 mm usually requires sentinel lymph node biopsy 
 
 
- Diagnosis: Excisional biopsy with > 2 mm margins (never shave biopsy) 
Management:
- Prevent excess sun exposure 
- Excision - <1 mm depth: 1 cm margins 
- 1-2 mm depth: >1 cm margins 
- > 2 mm depth: 2 cm margins 
- Face: Resect to level of muscles of expression 
- Parotid: Resect to masseteric fascia 
- Scalp: Resect to calvarial periosteum 
- Auricle: Partial or total auriculectomy 
- EAC: Possible temporal bone resection 
 
- Sentinel Node Biopsy - Replaced elective neck dissection 
- Neck dissection reserved for positive nodes 
- Predictive of overall and disease-free survival 
 
- Chemo/Immuno/Molecular therapy 
- Radiation: typically reserved for non-surgical and palliative patients 
Image 1
Image 2
Image 1 Reference: Scatena C, Murtas D., Tomei S. Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies. Front Oncology. 2021 May; 11.
Image 2 Reference: Lopes, Joana & Rodrigues, Cecilia & Gaspar, Manuela & Reis, Catarina. (2022). Melanoma Management: From Epidemiology to Treatment and Latest Advances. Cancers. 14. 4652.
Further Reading:
General
Sentinel Node Biopsy
Surgical Management
Surgical Management 2
Chemo/Immuno/Molecular Therapy
Immunotherapy
Written by: Graham Pingree
 
            
              
            
            
          
              